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OBJECTIVES We evaluated whether endothelial dysfunction was present in nondiabetic persons with a
family history (FH) of diabetes and assessed its relationship with insulin resistance and
atherosclerosis risk factors.
BACKGROUND Atherosclerosis is frequently present when type 2 diabetes (T2D) is first diagnosed.
Endothelial dysfunction contributes to atherogenesis.
METHODS Oral glucose tolerance and brachial artery flow-mediated, endothelium-dependent vasodila-
tion (EDV) were assessed in 38 nondiabetic subjects; offspring of two parents with T2D
(FH) or with no first-degree relative with diabetes (FH).
RESULTS Although fasting glucose was higher in FH than FH (5.3  0.1 mmol/l vs. 4.9  0.1
mmol/l, p  0.03), glycemic burden assessed as 2-h or area-under-the-curve glucose after
glucose load or glycosylated hemoglobin (HbA1c), and measures of insulin sensitivity or
inflammation did not differ. Brachial artery flow-mediated EDV was reduced in FH (7.1
0.9% vs. 11.7  1.6%, p  0.02), with no difference in nitroglycerin-induced endothelium-
independent vasodilatation. In the combined cohort, only FH (r2  0.12, p  0.02) and
HbA1c (r2  0.14, p  0.02) correlated with EDV. Insulin resistance, assessed by tertile of
homeostasis model assessment of insulin resistance (HOMA-IR), was associated with
impaired endothelium-dependent vasodilatation in FH (p 0.03, analysis of variance), but
not in FH, as even the most insulin-sensitive FH offspring had diminished endothelial
function. In multiple regression analysis, including established cardiac risk factors, blood
pressure and lipids, HbA1c, and HOMA-IR, FH remained a significant determinant of
EDV (p  0.04).
CONCLUSIONS Bioavailability of nitric oxide is lower in persons with a strong FH of T2D. Glycemic burden,
even in the nondiabetic range, can contribute to endothelial dysfunction. Abnormalities
of endothelial function may contribute to atherosclerosis before development of overt
diabetes. (J Am Coll Cardiol 2006;47:2456–61) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.045Cardiology Foundation
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iardiovascular disease is the leading cause of morbidity and
ortality for patients with diabetes. Atherosclerosis is fre-
uently present on diagnosis of type 2 diabetes (T2D),
uggesting atherosclerotic processes begin before the onset
f overt diabetes. Insulin resistance is highly associated with
2D, hypertension, dyslipidemia, obesity, and cardiovascu-
ar disease. Insulin resistance precedes and predicts both
ncident diabetes and cardiovascular disease. However, re-
ent studies suggest insulin resistance per se may impart
reater risk for development of diabetes in offspring of two
arents with T2D than in persons with no family history
FH) of disease (1). Whether insulin resistance imparts
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Manuscript received October 18, 2005; revised manuscript received February 1,
006, accepted February 14, 2006.ncreased cardiovascular risk in persons with a strong FH of
iabetes remains unknown.
The endothelium participates in atherosclerotic patho-
enesis. Attenuated function is considered an early marker
f vascular disease. Although some studies demonstrated
ndothelial dysfunction in persons with FH of diabetes
2,3), this remains controversial (4). We hypothesized that
ascular function among offspring of parents with diabetes is
bnormal compared with persons with no FH of diabetes or
oronary artery disease, even when traditional cardiac risk
actors are similar. We characterized inter-relationships
mong insulin resistance, cardiac risk factors, and endothe-
ial function according to FH of diabetes.
ETHODS
he study was approved by the institutional review board.
hirty-eight nondiabetic healthy subjects, 19 with two T2D
arents (FH) and 19 with no first-degree relative with
iabetes or coronary artery disease (FH), provided written
nformed consent. Family history was defined during med-
cal interview by participant report of either diabetes in both
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June 20, 2006:2456–61 Family History of Diabetes and the Endotheliumiological parents (FH), or in neither biological parent or
ny first-degree relative (FH). The FH cohort has been
reviously described (5). The FH cohort were recruited to
e similar for age, gender, and body mass index. All were
ormotensive and non-smokers.
Fasting lipids and oral glucose tolerance, using a 100-g
lucose load to maximize glucose and insulin excursion,
ere evaluated. Subjects were deemed nondiabetic using
ational Diabetes Data Group criteria (6,7). Areas under
he curve for glucose and insulin were calculated by trian-
ulation, and insulin resistance was determined by ho-
eostasis model assessment (HOMA-IR).
ascular function studies. Endothelial function was de-
ermined using high-resolution ultrasonography (Toshiba
owervision 8000, 7.5 MHz linear-array probe, Toshiba
merica Medical Systems, Inc., Tustin, California) trig-
ered by electrocardiogram “R” wave with Data Translation
rame-grabber videocard (Dataviz, Trumbull, Connecticut)
s previously described (5). A sphygmomanometric cuff
laced above the antecubital fossa was inflated to suprasys-
olic pressure for 5 min. Flow-induced, endothelial-
ependent vasodilation (EDV) was determined 1 min after
uff deflation. Endothelium-independent vasodilation
EIV) was determined 3 min after nitroglycerin, 0.4 mg
ublingually, which was withheld for systolic blood pressure
100 mm Hg (four subjects in each group). Arterial
iameter was measured using edge detection software (Bra-
hial Tools 4.2.2, Medical Imaging Applications LLC,
owa City, Iowa).
ssays. Glucose, lipids, and glycohemoglobin were measured
n the Joslin clinical laboratory. Immunoassays were performed
n duplicate and included serum insulin (Diagnostic Systems
aboratories, Webster, Texas), high-sensitivity C-reactive
rotein (Alpha Diagnostic International, San Antonio,
exas), interleukin-6 (R&D Systems, Inc., Minneapolis,
innesota), FFA (Wako Chemicals Inc., Richmond, Vir-
inia), plasma plasminogen activator inhibitor-1 (American
iagnostica, Greenwich, Connecticut), soluble intercellular
dhesion molecule-1 (R&D Systems), soluble CD40 ligand
BenderMedSystems, Vienna, Austria), and adiponectin
Linco Research, Inc., St. Charles, Missouri).
tatistical analysis. The unpaired t test was used for
Abbreviations and Acronyms
EDV  endothelium-dependent vasodilation
EIV  endothelium-independent vasodilation
FH  family history
FH  subjects with both parents having
type 2 diabetes
FH  subjects with no first-degree relative with
diabetes or coronary artery disease
HbA1c  glycosylated hemoglobin
HOMA-IR  homeostasis model assessment of
insulin resistance
T2D  type 2 diabetesomparison of FH and FH. Pearson’s correlation, Unalysis of variance (ANOVA), and simple, stepwise, and
ultiple regression analyses were performed using StatView
SAS Institute Inc., Cary, North Carolina). Independent
ariables were assessed directly and after logarithmic trans-
ormation for skewed distribution. Because no data became
niquely significant after logarithmic transformation, all
ata are presented as natural variables. Results are consid-
red significant with two-tailed p values 0.05.
ESULTS
tudy subjects. No subject had diabetes. Glycosylated
emoglobin (HbA1c) was within normative range (4% to
%) in all participants. Ten subjects in each group had 2-h
lucose concentrations between 7.8 to 11.1 mmol/l, sug-
esting some glucose intolerance. Demographic and meta-
olic characteristics are summarized (Table 1). Although
asting glucose was higher in FH than FH (5.3  0.1
mol/l vs. 4.9  0.1 mmol/l, respectively, p  0.03), no
ignificant differences existed in all other measures of
lycemia including 2-h glucose, area-under-the-curve glu-
ose, or HbA1c. Plasminogen activator inhibitor-1 tended
o be higher in FH (p  0.07), largely due to one FH
ubject. All other metabolic and inflammatory measures did
ot differ between groups.
DV and FH of diabetes. Endothelium-dependent va-
odilation was 38% lower in FH than FH (7.1 
.9% vs. 11.7  1.6%, p  0.02). There was no difference
etween groups in EIV (18.9  1.3% vs. 18.3  1.7%, p 
.8) (Fig. 1). Baseline diameter of the brachial artery was
imilar (3.6  0.2 mm vs. 3.5  0.1 mm, p  0.8, FH vs.
H, respectively).
DV and insulin resistance. To assess the relationship
etween HOMA-IR and EDV, the entire cohort was
ivided into tertiles of insulin resistance (1.3, 1.3 to 2.6,
nd 2.6). In two-way ANOVA, FH remained an impor-
ant determinant of EDV (p  0.03). There was no
ifference in EDV in the two most insulin-sensitive sub-
roups, but the most resistant tertile had significantly lower
DV (Fig. 2). The same boundary levels of HOMA-IR
ere then applied to FH and FH; thus, groups were
imilar in magnitude of insulin resistance. Each tertile was
epresented in FH and FH. The same pattern was seen
or insulin resistance and EDV in FH as in the whole
ohort. Specifically, the most insulin-resistant persons had
bnormal EDV. However, in FH, EDV was impaired in
ll three tertiles of insulin sensitivity, and there was no
elationship between EDV and HOMA-IR. Similar rela-
ionships were obtained using a general linear model anal-
sis with HOMA-IR and FH as covariates, accounting for
ultiple comparisons.
Although insulin resistance was demonstrated to interact
ith endothelial function, HOMA-IR associated more
trongly with traditional cardiac risk factors, obesity, cho-
esterol, and blood pressure than with EDV (Table 2).
sing Bonferroni correction for multiple comparisons,
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ity, high-density lipoprotein, and triglycerides remained
ignificant.
DV and glycemic burden. In secondary analysis evaluat-
ng glycemia and traditional cardiac risk factors with endo-
helial function, relationships between EDV, FH, and each
etabolic variable were evaluated using simple regression
nalysis. In the combined cohort, only FH (r2  0.12, p 
.02) and HbA1c (r2  0.14, p  0.02) correlated inversely
ith EDV (Fig. 3), suggesting an important interaction
etween chronic glycemia and EDV, even in the normative
ange.
Next, we evaluated FH and FH subgroups indepen-
ently. In FH, HbA1c (r2  0.15, p  0.05), cholesterol
r2  0.38, p  0.005), and systolic blood pressure (r2 
.23, p  0.04) each correlated inversely with EDV. In
H, only high-density lipoprotein directly associated with
Table 1. Baseline Characteristics of FH and
FH
n (men/women) 9/1
Age (yrs) 38.0 
BMI (kg/m2) 27.0 
Cholesterol (mmol/l) 4.57 
Triglycerides (mmol/l) 1.13 
HDL (mmol/l) 1.39 
Systolic BP (mm Hg) 119 
Diastolic BP (mm Hg) 70 
Fasting insulin (pmol/l) 63.3 
2-h insulin (pmol/l) 868 
Fasting glucose (mmol/l) 5.3 
2-h glucose (mmol/l) 7.5 
AUC glucose (arbitrary units) 17.8 
HbA1c (%) 5.1 
HOMA-IR 2.2 
hsCRP (mg/l) 2.2 
FFA (mEq/l) 0.72 
Adiponectin (g/dl) 7.1 
PAI-1 (ng/ml) 120 
IL-6 (pg/ml) 2.4 
sCD40L (ng/ml) 1.8 
AUC  area under the curve; BMI  body mass index; BP
HbA1c  glycosylated hemoglobin; HDL  high-density lip
resistance; hsCRP  high-sensitivity C-reactive protein; IL
sCD40L  soluble CD40 ligand.igure 1. Endothelium-dependent vasodilatation is impaired in offspring of two
f diabetes (FH). Endothelium-independent vasodilatation is not impaired.DV (r2  0.31, p  0.02), as previously reported (5). In
ontrast with FH, there was no association between EDV
nd cholesterol or systolic blood pressure in FH; EDV
as attenuated across the normative range of these variables
Fig. 4). Although significant relationships might become
vident with larger cohorts, these data suggest the strength
f the relationship between EDV and traditional cardiac
isk factors may differ in FH and FH. Furthermore,
H demonstrate blunted endothelial function across the
ange of cholesterol and systolic pressure, suggesting pro-
ective benefits of low blood pressure or low cholesterol on
DV is attenuated in FH.
In multiple regression analysis of the entire cohort,
ncorporating only independent variables significantly cor-
elated in the whole cohort or in either FH or FH
ubgroups (FH, HbA1c, HOMA-IR, cholesterol, high-
ensity lipoprotein cholesterol, and systolic blood pressure);
Subjects
FH p Value
9/10 0.6
36.5  2.0 0.5
26.7  1.2 0.8
4.86  0.17 0.3
1.45  0.29 0.3
1.36  0.10 0.8
120  4 0.9
70  2 0.8
50.3  7.2 0.2
705  125 0.5
4.9  0.1 0.03
7.4  0.4 0.9
17.1  0.7 0.6
5.0  0.1 0.3
1.7  0.2 0.2
1.7  0.4 0.4
0.64  0.04 0.3
6.6  0.9 0.7
57  9 0.07
3.0  0.9 0.5
1.7  0.2 0.9
ood pressure; FFA  free fatty acid; FH  family history;
ein; HOMA-IR  homeostasis model assessment of insulin
interleukin-6; PAI-1  plasminogen activator inhibitor-1;FH

0
2.0
1.0
0.22
0.13
0.09
4
2
7.3
152
0.2
0.5
0.8
0.1
0.3
0.5
0.7
1.0
30
0.4
0.3
 bl
oprotdiabetic parents (FH) compared to with persons without family history
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June 20, 2006:2456–61 Family History of Diabetes and the Endotheliumnly FH (p  0.04) remained a significant determinant of
DV. We fit bivariate models with FH and each major
ardiac risk factor as predictors, along with their interaction
ith FH and found significant interactions between FH and
oth cholesterol (p  0.004) and systolic blood pressure
p  0.03). Additionally, the main effects of the risk factors
f cholesterol and blood pressure were significant (p 
.0009 and p  0.01, respectively) as was FH status (p 
.01 in each model), indicating they are indeed indepen-
ently predictive of EDV even in the presence of FH, and
hat FH is an independent predictor of EDV. These data
uggest adverse effects of FH on EDV are mediated in part,
ut not solely, through blood pressure and lipids, even when
hese measures are normative. Due to differences in fasting
lucose between groups, the analysis was repeated including
asting glucose in the model. Family history remained a
ignificant determinant of EDV (p  0.03).
nflammation and endothelial function. Relationships
etween EDV and inflammatory cytokine/adipokine mea-
ures of inflammatory mediators did not correlate with
able 2. Relationship Between HOMA-IR and Cardiac
isk Factors
MI r2  0.20, p  0.007
aist/hip r2  0.31, p  0.0003
holesterol r2  0.17, p  0.008
riglycerides (log) r2  0.27, p  0.002
DL r2  0.23, p  0.003
ystolic BP r2  0.11, p  0.05
iastolic BP r2  0.11, p  0.03
igure 2. The whole cohort was divided into tertiles of homeostasis model a
nsulin sensitive and the highest tertile most resistant. The same levels of
istory (FH) and negative family history (FH) groups. There was redu
f the whole cohort, and in the most insulin-resistant FH group as comp
elationship between HOMA-IR and EDV in FH, such that even thedbbreviations as in Table 1.DV in the whole cohort, or in either FH or FH
ubgroups.
ISCUSSION
ur study demonstrates reduced EDV in nondiabetic indi-
iduals with strong FH compared with persons with no FH
f diabetes. Differences cannot be explained by confounding
ariables including age, gender, ethnicity, obesity, lipids,
lood pressure, glycemia, or insulin resistance. Although we
id not find associations between EDV and age or obesity
reviously reported in population-based studies (8), ranges
f these variables were smaller in our healthy cohort. In
ultiple regression analysis, only FH remained a significant
eterminant of EDV. Furthermore, endothelial dysfunction
as demonstrated in even the most insulin-sensitive off-
pring of diabetic parents. Although the pleiotropic meta-
olic disturbances of the pre-diabetic state may contribute
dditively or synergistically to atherosclerosis pathogenesis,
ur findings suggest a strong FH of diabetes is indepen-
ently associated with diminished EDV and may contribute
o cardiovascular risk in advance of overt diabetes. Frequent
resence of vascular pathology at the time of diagnosis of
iabetes suggests importance for identification of pre-
iabetic persons with diminished endothelial function and
arly atherosclerotic disease, and FH of diabetes is a
ecognized risk for development of diabetes.
Several previous investigations also found endothelial
ent of insulin resistance (HOMA-IR), such that the lowest tertile is most
A-IR were then applied to define the subgroups within positive family
ndothelium-dependent vasodilation (EDV) in the most resistant persons
to with either of the two more sensitive subgroups; however, there was no
insulin-sensitive offspring had attenuated EDV. *p  0.05.ssessm
HOM
ced eysfunction in offspring of diabetic parents (2,3), though
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Family History of Diabetes and the Endothelium June 20, 2006:2456–61his remains controversial (4). In these studies, offspring
ohorts differed from control subjects with respect to post-
oad glucose and insulin, cholesterol, severity of insulin
igure 3. Simple linear regression is demonstrated between endothelium-
ependent vasodilatation (EDV) and glycosylated hemoglobin (HbA1c),
emonstrating within normal range higher glycemic burden associates with
ttenuated EDV. Individual data are presented for subjects with a family
istory of diabetes (FH) (solid circles) and subjects without a family
istory of diabetes (FH) (open circles).
igure 4. Simple linear regression is demonstrated with endothelium-de
ipoprotein (HDL) and systolic blood pressure (BP) as independent variab
amily history of diabetes (FH). Individual data are presented for FH (s
emonstrate blunted endothelial dilation across the range of cholesterol and sysesistance, body mass index, blood pressure, and other
actors (2–4). Also, relationships between glucose metabolic
learance rate and endothelial function were not assessed in
ontrol subjects (3). These confounding differences make it
ifficult to assess independent effects of FH of diabetes on
ndothelial function. Our FH were offspring of two T2D
arents, contrasting with studies with just one of two
arents with diabetes, thereby enriching our group for
amilial differences. Moreover, our cohorts were similar for
ultiple confounding variables, yet attenuation of EDV was
ignificant in offspring.
yperglycemia and endothelial function. Both hypergly-
emia and insulin resistance could contribute to atheroscle-
osis. In the absence of overt diabetes, multiple studies have
ound that either impaired fasting or 2-h post-load glucose
redicts cardiovascular events (9,10). Fasting hyperglycemia
iminishes microvascular hyperemia (11) and inversely cor-
elates with EDV (8), and short-term hyperglycemia atten-
ates endothelial function in healthy persons (12). Hyper-
lycemia may adversely affect vascular function through
ultiple mechanisms including increased flux through the
olyol pathway, increased oxidative stress, activation of
rotein kinase C-beta, and advanced-glycation end products
ent vasodilation as the dependent variable and cholesterol high-density
subjects with a family history of diabetes (FH) and subjects without apend
les inolid circles) and FH (open circles). Positive family history subjects
tolic pressure.
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June 20, 2006:2456–61 Family History of Diabetes and the Endotheliumormation (13). We evaluated nondiabetic cohorts with
ormal-to-mild glucose intolerance enriching our cohorts
or risk of diabetes and early atherosclerotic pathology. This
s the first study to document an association between
ormative HbA1c and EDV in nondiabetic persons further
mplicating an important and adverse effect of very mild
levations in glucose on endothelial function. All subjects
ad normative fasting glucose, yet differences in glycemic
urden assessed by fasting glucose existed between groups.
herefore, we cannot discount the possibility that a mar-
inal increase in blood glucose contributes to attenuation in
ndothelial function in offspring.
nsulin resistance and endothelial function. Insulin re-
istance is associated with endothelial dysfunction, cardio-
ascular risk (14), and incident cardiovascular events in
pidemiology studies (15). Although our sample size is
mall, we found insulin resistance associates with impaired
DV. The relationship was predominant in FH, with
iminished endothelial function in the most insulin-
ensitive FH offspring. In Native Americans, another
igh-risk group for development of diabetes, HOMA-IR
as predictive of incident diabetes but not predictive of
ncident cardiovascular disease after adjustment for estab-
ished cardiac risk factors including body mass index, waist
ircumference, blood pressure, and lipids (16). Consistently,
e demonstrate HOMA-IR is more strongly related to
raditional cardiac risk factors than with EDV.
Subclinical inflammation is associated with insulin resis-
ance (17) and cardiovascular disease (18). In our study,
ndothelial dysfunction in FH offspring was not reflected
y differences in multiple inflammatory measures. Nonethe-
ess, other cytokines/adipokines could underlie attenuated
DV in offspring.
Although insulin resistance precedes development of
iabetes in high-risk cohorts including offspring of diabetic
arents, Pima Indians, and other ethnic minority popula-
ions, (6,19,20) insulin resistance per se may not be suffi-
ient for development of diabetes in Caucasian persons
ithout FH of disease who are at lower risk (1). A FH of
iabetes, therefore, may impart additional factor(s) permis-
ive for progression to disease. As FH of diabetes remains
ignificantly correlated with endothelial function, it is inter-
sting to speculate whether similar environmental or genetic
isk factor(s) not assessed in current measures underlies both
ndothelial dysfunction and predisposition to diabetes.
onclusions. We demonstrate that nondiabetic offspring
f diabetic parents have impaired EDV. These data suggest
ioavailability of nitric oxide is lower in offspring of two
2D parents and may contribute to cardiovascular risk in
dvance of development of overt diabetes. Modest hyper-
lycemia, even within the normative range, may contribute
o attenuated endothelial function. Finally, as endothelial
ysfunction is present in nondiabetic offspring of diabetic
arents, strong FH of T2D could be considered an addi-
ional cardiac risk factor.eprint requests and correspondence: Dr. Allison B. Goldfine,
oslin Diabetes Center, One Joslin Place, Boston, Massachusetts
2215. E-mail: allison.goldfine@joslin.harvard.edu.
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